Genetically predicted serum metabolites mediate the association between inflammatory proteins and polycystic ovary syndrome: a Mendelian randomization study
2024

Inflammatory Proteins and Polycystic Ovary Syndrome: A Mendelian Randomization Study

Sample size: 220609 publication 10 minutes Evidence: high

Author Information

Author(s): Jia Ming-Jie, Zhou Li, Liu Xing-Ning, Li Hui-Lin

Primary Institution: The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, China

Hypothesis

This study investigates the association between polycystic ovary syndrome (PCOS) and inflammatory proteins, and identifies serum metabolites as potential mediators.

Conclusion

The study reveals novel causal associations between inflammatory proteins and PCOS, highlighting the mediating role of serum metabolites.

Supporting Evidence

  • The study identified four inflammatory proteins significantly associated with PCOS.
  • Serum metabolite X-11444 was found to mediate 5.44% of the effect of MMP-10 on PCOS.
  • IL-6 and MMP-10 were associated with decreased risk of PCOS.
  • IFN-γ and CCL7 were associated with increased risk of PCOS.

Takeaway

This study shows that certain proteins in the body can affect the risk of a condition called PCOS, and some substances in the blood help explain how this happens.

Methodology

The study used a two-sample Mendelian Randomization analysis with summary-level data from genome-wide association studies.

Potential Biases

Potential biases from population stratification and the lack of stratified analysis by PCOS phenotypes.

Limitations

The study's focus on individuals of European ancestry may limit the generalizability of the findings to other populations.

Participant Demographics

The study involved 1,639 cases of PCOS and 218,970 controls, primarily of European descent.

Statistical Information

P-Value

0.015, 0.025, 0.033, 0.037

Confidence Interval

95% CI: 1.020–1.910, 95% CI: 1.021–1.641, 95% CI: 0.495–0.929, 95% CI: 0.587–0.967

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fmed.2024.1433612

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication